Oculis (OCS) Institutional Ownership → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free OCS Stock Alerts $12.02 +0.07 (+0.59%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Oculis (NASDAQ:OCS)CurrentInstitutional OwnershipPercentage22.30%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$22.21MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$5.98M Get OCS Insider Trade Alerts Want to know when executives and insiders are buying or selling Oculis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OCS Institutional Buying and Selling by Quarter Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Oculis Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024Pivotal bioVenture Partners Investment Advisor LLC1,888,788$21.21M5.4%-14.9%5.190% 2/6/2024Searle & CO.10,000$112K0.0%N/A0.027% 1/31/2024abrdn plc1,452,741$15.98M0.0%N/A3.992% 1/16/2024Compagnie Lombard Odier SCmA95,750$1.05M0.0%+47.3%0.263% 11/14/2023Nan Fung Group Holdings Ltd606,684$6.67M5.4%-6.8%1.667% 11/14/2023Pivotal bioVenture Partners Investment Advisor LLC2,218,754$24.41M9.7%-6.8%6.097% 11/13/2023Wolverine Asset Management LLC7,021$77K0.0%N/A0.019% 9/21/2023Barclays PLC3,602$44K0.0%N/A0.010% 5/12/2023Nan Fung Group Holdings Ltd651,100$4.84M3.3%N/A1.989% 5/1/2023Compagnie Lombard Odier SCmA65,000$472K0.0%N/A0.199% (Data available from 1/1/2016 forward) OCS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OCS shares? During the previous two years, the following institutional investors and hedge funds held shares of Oculis shares: Pivotal bioVenture Partners Investment Advisor LLC ($21.21M), abrdn plc ($15.98M), Nan Fung Group Holdings Ltd ($6.67M), Compagnie Lombard Odier SCmA ($1.05M), Searle & CO. ($112K), and Wolverine Asset Management LLC ($77K), and Barclays PLC ($44K).Learn more on OCS's institutional investors. What percentage of Oculis stock is owned by institutional investors? 22.30% of Oculis stock is owned by institutional investors. Learn more on OCS's institutional investor holdings. Which institutional investors have been buying Oculis stock? The following institutional investors have purchased Oculis stock in the last 24 months: abrdn plc ($1.45M), Nan Fung Group Holdings Ltd ($651.10K), Compagnie Lombard Odier SCmA ($95.75K), Searle & CO. ($10K), Wolverine Asset Management LLC ($7.02K), and Barclays PLC ($3.60K). How much institutional buying is happening at Oculis? Institutional investors have bought a total of 2,220,214 shares in the last 24 months. This purchase volume represents approximately $22.21M in transactions. Which Oculis major shareholders have been selling company stock? The following institutional investors have sold Oculis stock in the last 24 months: Pivotal bioVenture Partners Investment Advisor LLC ($492.41K), and Nan Fung Group Holdings Ltd ($44.42K). How much institutional selling is happening at Oculis? Institutional investors have sold a total of 536,824 shares in the last 24 months. This volume of shares sold represents approximately $5.98M in transactions. Related Companies: KALV Institutional Ownership TBPH Institutional Ownership TVTX Institutional Ownership SLRN Institutional Ownership LRMR Institutional Ownership ANNX Institutional Ownership FULC Institutional Ownership CDMO Institutional Ownership MRSN Institutional Ownership NGNE Institutional Ownership This page (NASDAQ:OCS) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
